Suchergebnisse - "Riveiro-Barciela, Mar"

PubPharm (168)

81

Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management

enthalten in: Therapeutic advances in gastroenterology | 2021

von Grau-López, L. | Marcos-Fosch, C. | Daigre, C. | +11

82

Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy

enthalten in: PloS one | 2021

von Llorens-Revull, M. | Costafreda, M. | Rico, A. | +12

83

Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B

enthalten in: Therapeutic advances in infectious disease | 2021

von Roade, L. | Riveiro-Barciela, M. | Esteban, R. | +1

84

One‐quarter of chronic hepatitis D patients reach HDV‐RNA decline or undetectability during the natural course of the disease

enthalten in: Alimentary Pharmacology & Therapeutics | 2021

von Palom, A. | Sopena, S. | Riveiro‐Barciela, M. | +14

85

Differential characteristics and outcomes of Asian and non‐Asian patients with HBV‐related hepatocellular carcinoma

enthalten in: Liver International | 2021

von Huang, D. | Hoang, J. | Leong, J. | +11

86

Toxicities from immunotherapy : From clinical trials to real-world clinical practice

enthalten in: Medicina clinica | 2020

von Riveiro-Barciela, M. | Trallero-Araguás, E. | Martínez-Valle, F. | +6

87

Outcome and risk of de novo Hepatitis B after liver transplantation : Are all anti-HBc-positive grafts the same?

enthalten in: Clinics and research in hepatology and gastroenterology | 2020

von Riveiro-Barciela, M.

88

Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Roade, L. | Loglio, A. | Borghi, M. | +9

89

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

enthalten in: The New England journal of medicine | 2020

von Severe Covid-19 GWAS Group | Ellinghaus, D. | Degenhardt, F. | +98

CommentIn: N Engl J Med. 2020 Oct 15;383(16):1590-1591. - PMID 33053291

90

Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study

enthalten in: Digestive diseases and sciences | 2020

von Ferre-Aracil, C. | Riveiro-Barciela, M. | Trapero-Marugán, M. | +11